Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

C. Le Pechoux; A. Laplanche; C. Faivre-Finn; T. Ciuleanu; R Wanders; D. Lerouge; R. Keus; M. Hatton; G.M. Videtic; S. Senan; A. Wolfson; R. Jones; R. Arriagada; E. Quoix; A. Dunant

doi:10.1093/annonc/mdq576

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

C. Le Pechoux, A. Laplanche, C. Faivre-Finn, T. Ciuleanu, R Wanders, D. Lerouge, R. Keus, M. Hatton, G.M. Videtic, S. Senan, A. Wolfson, R. Jones, R. Arriagada, E. Quoix, A. Dunant

Radiation Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1154-1163
Journal	Annals of Oncology
Volume	22
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mdq576
Publication status	Published - 2011

Access to Document

10.1093/annonc/mdq576

Cite this

Le Pechoux, C., Laplanche, A., Faivre-Finn, C., Ciuleanu, T., Wanders, R., Lerouge, D., Keus, R., Hatton, M., Videtic, G. M., Senan, S., Wolfson, A., Jones, R., Arriagada, R., Quoix, E., & Dunant, A. (2011). Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Annals of Oncology, 22(5), 1154-1163. https://doi.org/10.1093/annonc/mdq576

Le Pechoux, C. ; Laplanche, A. ; Faivre-Finn, C. et al. / Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). In: Annals of Oncology. 2011 ; Vol. 22, No. 5. pp. 1154-1163.

@article{1329a2171a984446a482432f5ebc2537,

title = "Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)",

author = "{Le Pechoux}, C. and A. Laplanche and C. Faivre-Finn and T. Ciuleanu and R Wanders and D. Lerouge and R. Keus and M. Hatton and G.M. Videtic and S. Senan and A. Wolfson and R. Jones and R. Arriagada and E. Quoix and A. Dunant",

year = "2011",

doi = "10.1093/annonc/mdq576",

language = "Undefined/Unknown",

volume = "22",

pages = "1154--1163",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "5",

}

Le Pechoux, C, Laplanche, A, Faivre-Finn, C, Ciuleanu, T, Wanders, R, Lerouge, D, Keus, R, Hatton, M, Videtic, GM, Senan, S, Wolfson, A, Jones, R, Arriagada, R, Quoix, E & Dunant, A 2011, 'Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)', Annals of Oncology, vol. 22, no. 5, pp. 1154-1163. https://doi.org/10.1093/annonc/mdq576

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). / Le Pechoux, C.; Laplanche, A.; Faivre-Finn, C. et al.

In: Annals of Oncology, Vol. 22, No. 5, 2011, p. 1154-1163.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

AU - Le Pechoux, C.

AU - Laplanche, A.

AU - Faivre-Finn, C.

AU - Ciuleanu, T.

AU - Wanders, R

AU - Lerouge, D.

AU - Keus, R.

AU - Hatton, M.

AU - Videtic, G.M.

AU - Senan, S.

AU - Wolfson, A.

AU - Jones, R.

AU - Arriagada, R.

AU - Quoix, E.

AU - Dunant, A.

PY - 2011

Y1 - 2011

U2 - 10.1093/annonc/mdq576

DO - 10.1093/annonc/mdq576

M3 - Article

C2 - 21139020

VL - 22

SP - 1154

EP - 1163

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 5

ER -

Le Pechoux C, Laplanche A, Faivre-Finn C, Ciuleanu T, Wanders R, Lerouge D et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Annals of Oncology. 2011;22(5):1154-1163. https://doi.org/10.1093/annonc/mdq576